Glycemic Control with Ipragliflozin, a Novel Selective SGLT2 Inhibitor, Ameliorated Endothelial Dysfunction in Streptozotocin-Induced Diabetic Mouse

BACKGROUND: Endothelial dysfunction caused by increased oxidative stress is a critical initiator of macro- and micro-vascular disease development in diabetic patients. Ipragliflozin, a selective sodium-glucose cotransporter 2 (SGLT2) inhibitor, offers a novel approach for the treatment of diabetes b...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Front Cardiovasc Med
Huvudupphovsmän: Salim, Hotimah Masdan, Fukuda, Daiju, Yagi, Shusuke, Soeki, Takeshi, Shimabukuro, Michio, Sata, Masataka
Materialtyp: Artigo
Språk:Inglês
Publicerad: Frontiers Media S.A. 2016
Ämnen:
Cardiovascular Medicine
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5080286/
https://ncbi.nlm.nih.gov/pubmed/27833913
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2016.00043
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk